Clinical Case Webinars: Assessing and managing alcohol use and OUD
- Tuesday, 15 September 2026
- 6:00 – 7:00 PM
- Facilitated by Dr Joshua Watt, Staff Specialist Addiction Medicine, SLHD Drug Health Services and Clinical Lecturer, Central Clinical School, University of Sydney.
Register Here
Webinar Recordings
Life after Sublocade: Supporting Patients Through the Change Ahead
- Date Recorded: 18 August 2026
- Dr Hester Wilson, Chief Addiction Medicine Specialist for NSW Ministry of Health, Clinical Director for Murrumbidgee Drug and Alcohol Service for Murrumbidgee Local Health District, chair of the RACGP Addiction Special Interest Group, and a GP in private practice and Dr Jenny James, GP Specialist, VMO GP Drug Health Services, South Western Sydney LHD
- Discontinuation of Sublocade from the NSW Opioid Treatment Program
- LAIB Guidance - Pharmacokinetics on page 23
Share feedback
Nitrous oxide and GHB use among people who use opioids
- Date Recorded: 21 July 2026
- Dr Emily Symes, Staff Specialist Clinical Toxicology, Drug Health Services RPA; VMO Emergency Medicine, Canterbury Emergency Department; Postgraduate Fellow Clinical Toxicology, NSW Poisons Information Centre, PhD Candidate NDARC
Share feedback
- Date Recorded: 23 June 2026
- Dr Huw Davie, Head of Department, Drug Health Services, Concord & Canterbury Hospital SLHD
Share feedback
- Date Recorded: 9 June 2026
- Dr Nicholas Kortt, Staff Specialist, Drug Health Service Concord and Canterbury Hospital and Staff Specialist, Liver Clinic Canterbury Hospital, Sydney Local Health District
Share feedback
- Date Recorded: 12 May 2026
- Prof Adrian Dunlop, Director and Addiction Medicine Senior Staff Specialist, Drug & Alcohol Clinical Services, Hunter New England Local Health District and an author of the NSW LAIB Guidance.
Share feedback
- Date Recorded: 17 March 2026
- Dr Kelly McNamara, Obstetrics and gynaecology Specialist and Senior Lecturer, School of Medicine and Public Health, University of Newcastle
- Dr Vicki Chase, Addiction Medicine Specialist, Central Coast LHD.
Share feedback
- Date Recorded: 17 February 2026
- Dr Mark A Hardy, Director of Medical Services, Drug Health Services, South Western Sydney LHD
Share feedback
Archive
2025 Webinars
- Takeaways for Holidays and All-Year
- Child Safety and Child Protection Issues & Considerations for People Receiving Opioid Agonist Treatment (OAT)
- Palliative Care in People with Drug Dependence
- The Impact of Opioids on the Endocrine System
- Urine Drug Screen and Management of Results
- Music Festival Harm Reduction and Drug Checking in NSW
- Supervised Injection for Harm Reduction
- Mental Health Issues in People with Opioid Use Disorder
- Getting Behind the Wheel: Driving Safety & OAT
- New and Uncommon Opioids You May Encounter
2024 Webinars
- Drugs, Alcohol, and the Liver
- Preparing Opioid Treatment Programs for the Unexpected- Disaster Planning
- Updates to the Long-acting Injectable Buprenorphine (LAIB) Guidance
- Clinical Guidance for Management of Substance Use in Pregnancy, Birth and the Postnatal Period
- Common Side Effects Related to OAT
- Are We Better Off (Patients, Pharmacists, Prescribers)?
- Management of Medicinal and Non-Medical Cannabis use Among OAT Clients
- Providing Harm Reduction Services to People Receiving OAT
- Opioid Agonist Treatment and Custodial Settings
- Updates to OTP Approval Management Functionality in SafeScript NSW
2023 Webinars
- Planning for Holidays & Provisions for Unexpected Leave
- Identification & Management of QT Prolongation with OAT Clients
- Chronic Pain Management & OAT
- OTP Prescribing for Non-Accredited Healthcare Professionals
- The Role of SafeScript NSW with OAT
- Acute Pain Management with OAT
- Changes to OTP under the Pharmaceutical Benefits Scheme
- Common Clinical Challenges in OAT
- Sedating Substances and OAT
- Buprenorphine Transition Challenges